Adhesion Barrier Market | Discover The Latest Trends, Drivers, Restraints, Opportunities and Industry-Specific Challenges
The growth of adhesion
barrier market is driven by the growth in the geriatric population and
corresponding age-related chronic diseases, epidemiological shift from
infectious to chronic diseases, growing volume of surgical procedures and
sports-related injuries, and increasing awareness about the medical
complications occurred due to post-surgical adhesion formation.
What the adhesion barrier market looks like?
The global adhesion barrier market is projected to reach USD 806.4 Million by 2023 from USD 570.7 Million in 2018, at a CAGR of 7.2%.
Increasing awareness about the medical implications of adhesions:
Post-surgical adhesions are a common complication in various types of surgeries. The knowledge and understanding of adhesions and adhesion-related complications have increased in the last decade. Various surgical associations, as well as hospitals, are focusing on increasing the awareness about post-surgical adhesion formation and the available anti-adhesive products to control these complications.
According to a survey conducted by the European Society for Gynaecological Endoscopy (ESGE), in the UK, over 85% of respondents agreed that adhesions develop after any type of gynecological surgery, and more than 50% of respondents considered that adhesions were the most common complication of abdominal surgery. This is expected to increase the importance of anti-adhesion products in surgical procedures. Moreover, growing awareness about adhesion-related disorders in Asia Pacific countries such as India, Australia, and China is expected to further drive the demand for anti-adhesion products in the coming years.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=208132543
Adhesion Barrier Application:
The gynecological segment accounted for the largest share of the market in 2017. Factors such as the increasing number of C-section surgeries, rising incidence of pelvic/uterine cancer, and increasing prevalence of conditions such as infertility and incontinence responsible to drive this market.
Regional Growth and Demand of Adhesion Barrier:
Geographically, the global adhesion barrier market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America holds the largest share of this market in 2017. This is primarily due to the increase in the aging population, increasing number of soft tissue injuries and the consequent growth in the number of surgical procedures, higher government expenditure on healthcare, and well-established healthcare services across North America.
Asia Pacific region is expected to grow at a higher CAGR during the forecast period. The rising healthcare expenditure in these regions, growing volume of surgical procedures, and growing awareness about adhesions and their complications are driving the growth of these markets.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=208132543
The major players in the adhesion barriers industry are Johnson & Johnson (J&J) (US), Sanofi (France), Baxter International (US), C.R. Bard (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll Holdings (Ireland), Betatech Medical (Turkey), SyntheMed (US), Aziyo Biologics (US), Biom’up (France), Terumo Corporation (Japan), and BMI Korea Co. (South Korea).
What the adhesion barrier market looks like?
The global adhesion barrier market is projected to reach USD 806.4 Million by 2023 from USD 570.7 Million in 2018, at a CAGR of 7.2%.
Increasing awareness about the medical implications of adhesions:
Post-surgical adhesions are a common complication in various types of surgeries. The knowledge and understanding of adhesions and adhesion-related complications have increased in the last decade. Various surgical associations, as well as hospitals, are focusing on increasing the awareness about post-surgical adhesion formation and the available anti-adhesive products to control these complications.
According to a survey conducted by the European Society for Gynaecological Endoscopy (ESGE), in the UK, over 85% of respondents agreed that adhesions develop after any type of gynecological surgery, and more than 50% of respondents considered that adhesions were the most common complication of abdominal surgery. This is expected to increase the importance of anti-adhesion products in surgical procedures. Moreover, growing awareness about adhesion-related disorders in Asia Pacific countries such as India, Australia, and China is expected to further drive the demand for anti-adhesion products in the coming years.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=208132543
Adhesion Barrier Application:
The gynecological segment accounted for the largest share of the market in 2017. Factors such as the increasing number of C-section surgeries, rising incidence of pelvic/uterine cancer, and increasing prevalence of conditions such as infertility and incontinence responsible to drive this market.
Regional Growth and Demand of Adhesion Barrier:
Geographically, the global adhesion barrier market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America holds the largest share of this market in 2017. This is primarily due to the increase in the aging population, increasing number of soft tissue injuries and the consequent growth in the number of surgical procedures, higher government expenditure on healthcare, and well-established healthcare services across North America.
Asia Pacific region is expected to grow at a higher CAGR during the forecast period. The rising healthcare expenditure in these regions, growing volume of surgical procedures, and growing awareness about adhesions and their complications are driving the growth of these markets.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=208132543
The major players in the adhesion barriers industry are Johnson & Johnson (J&J) (US), Sanofi (France), Baxter International (US), C.R. Bard (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll Holdings (Ireland), Betatech Medical (Turkey), SyntheMed (US), Aziyo Biologics (US), Biom’up (France), Terumo Corporation (Japan), and BMI Korea Co. (South Korea).
Comments
Post a Comment